Kamel A - Search Results

1

Heterogeneity of antigen expression in advanced epithelial ovarian cancer.

Berchuck A, Olt GJ, Soisson AP, Kamel A, Soper JT, Boyer CM, Clarke-Pearson DL, Leslie DS, Bast RC Jr. Berchuck A, et al. Among authors: kamel a. Am J Obstet Gynecol. 1990 Apr;162(4):883-8. doi: 10.1016/0002-9378(90)91288-n. Am J Obstet Gynecol. 1990. PMID: 2327461

2

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, et al. Berchuck A, et al. Among authors: kamel a. Cancer Res. 1990 Jul 1;50(13):4087-91. Cancer Res. 1990. PMID: 1972347

3

Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina.

Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Among authors: kamel a. Obstet Gynecol. 1990 Sep;76(3 Pt 1):381-7. Obstet Gynecol. 1990. PMID: 1974342

4

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

Berchuck A, Rodriguez GC, Kamel A, Dodge RK, Soper JT, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Among authors: kamel a. Am J Obstet Gynecol. 1991 Feb;164(2):669-74. doi: 10.1016/s0002-9378(11)80044-x. Am J Obstet Gynecol. 1991. PMID: 1992720

5

Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy.

Vredenburgh JJ, Peters WP, Rosner G, DeSombre K, Johnston WW, Kamel A, Wu K, Bast RC Jr. Vredenburgh JJ, et al. Among authors: kamel a. Bone Marrow Transplant. 1995 Dec;16(6):815-21. Bone Marrow Transplant. 1995. PMID: 8750275 Clinical Trial.

6

Effect of intramural fibroid on uterine and endometrial vascularity in infertile women scheduled for in-vitro fertilization.

Kamel A, El-Mazny A, Ramadan W, Abdelaziz S, Gad-Allah S, Saad H, Hussein AM, Salah E. Kamel A, et al. Arch Gynecol Obstet. 2018 Feb;297(2):539-545. doi: 10.1007/s00404-017-4607-2. Epub 2017 Dec 14. Arch Gynecol Obstet. 2018. PMID: 29242974

7

Effect of hydrosalpinx on uterine and ovarian hemodynamics in women with tubal factor infertility.

El-Mazny A, Ramadan W, Kamel A, Gad-Allah S. El-Mazny A, et al. Among authors: kamel a. Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:55-9. doi: 10.1016/j.ejogrb.2016.01.046. Epub 2016 Feb 8. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 26897399

8

Reply to the comments on "Modified hysterectomy for placenta increta and percreta: modifications of what?".

Hussein AM, Kamel A. Hussein AM, et al. Among authors: kamel a. Arch Gynecol Obstet. 2019 Jun;299(6):1753-1755. doi: 10.1007/s00404-019-05118-8. Epub 2019 Mar 20. Arch Gynecol Obstet. 2019. PMID: 30895372 No abstract available.

9

Reply to letter to the editor article "Placenta accreta spectrum: "placenta accreta" is still used".

M Hussein A, Kamel A. M Hussein A, et al. Among authors: kamel a. Arch Gynecol Obstet. 2021 Jun;303(6):1631-1632. doi: 10.1007/s00404-020-05932-5. Epub 2021 Jan 17. Arch Gynecol Obstet. 2021. PMID: 33454807 No abstract available.

10

Modified cesarean hysterectomy technique for management of cases of placenta increta and percreta at a tertiary referral hospital in Egypt.

Hussein AM, Kamel A, Raslan A, Dakhly DMR, Abdelhafeez A, Nabil M, Momtaz M. Hussein AM, et al. Among authors: kamel a. Arch Gynecol Obstet. 2019 Mar;299(3):695-702. doi: 10.1007/s00404-018-5027-7. Epub 2019 Jan 4. Arch Gynecol Obstet. 2019. PMID: 30607590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

833 results

Search Page

Filters